Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by 4-aminopyridine in rat entorhinal cortex hippocampal slices

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 1, 1999, Pages 33-39

  Armand, V ^a,c   Rundfeldt, C ^b   Heinemann, U ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ASTA MEDICA AG   (Germany)

^c CENTRE PAUL BROCA   (France)

Author keywords

Anticonvulsant; Antiepileptic; Bicuculline; Field potential; New drug; Retigabine

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOPYRIDINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BICUCULLINE; CARBAMAZEPINE; GLUTAMATE RECEPTOR; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; PENICILLIN G; PENTETRAZOLE; PHENYTOIN; PICROTOXIN; RETIGABINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; BRAIN SLICE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENTORHINAL CORTEX; EPILEPTIC DISCHARGE; GABAERGIC TRANSMISSION; NONHUMAN; RAT; RECEPTOR BLOCKING;

EID: 0033032546     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005320     Document Type: Article

References (45)

1. Avoli M, Barbarosie M, Lücke A, Nagao T, Lopantsev V, Köhling R (1996) Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro. J Neurosci 16:3912-3924
2. A agonist muscimol Epilepsy Res 5:8-17
3. Dailey JW, Jobe PC (1985) Anticonvulsant drugs and genetically epilepsy-prone rat. Fed Proc 44:2640-2644
4. Dailey JW, Cheong JH, Ko KH, Adams-Curtis LE, Jobe PC (1995) Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: Prediction of clinical response. Neurosci Lett 195:77-80
5. Dreier JP, Heinemann U (1990) Late low magnesium-induced epileptiform activity in rat entorthinal cortex slices becomes insensitive to the anticonvulsant valproic acid. Neurosci Lett 119:68-70
6. Ficker E, Heinemann U (1992) Slow and fast transient potassium currents in cultured rat hippocampal cells. J Physiol (Lond) 445:431-455
7. Fueta Y, Avoli M (1992) Effects of antiepileptic drugs on 4-aminopyridine-induced epileptiform activity in young and adult rat hippocampus. Epilepsy Res 12:207-215
8. 2+ induced epileptiform activity in rat hippocampal and entorhinal cortex slices during adolescence. Brain Res Dev Brain Res 87:145-152
9. Gustafsson B, Galvan M, Grafe P, Wigström H (1982) A transient outward current in a mammalian central neurone blocked by 4-aminopyridine. Nature 299:252-254
10. Harvey AS, Grattan-Smith JD, Desmond PM, Chow CW, Berkovic SF (1995) Febrile seizures and hippocampal sclerosis: frequent and related findings in intractable temporal lobe epilepsy of childhood. Pediatr Neurol 12:201-206
11. Heinemann U, Arens J, Dreier JP, Stabel J, Zhang CL (1991) In vitro epileptiform activity: role of excitatory amino acids. Epilepsy Res 10:18-23
12. Heinemann U, Draguhn A, Ficker E, Stabel J, Zhang CL (1994). Strategies for the development of drugs for pharmacoresistant epilepsies. Epilepsia. 35 [Suppl 5]:S10-S21
13. 2+, TEA and 4-AP. Exp Brain Res 68:205-209
14. Kapetanovic IM, Rundfeldt C (1996) D-23129: A new anticonvulsant compound. CNS Drug Rev 2:308-321
15. Kapetanovic IM, Yonekawa WD, Kupferberg HJ (1995) The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vivo. Epilepsy Res 22:167-173
16. Köhr G, Heinemann U (1987) Anticonvulsive properties of ketamine and 2-aminophosphono-valerate in the low magnesium epilepsy in rat hippocampal slices. Neurosci Res Commun 1:17-21
17. Löscher W, Schmidt D (1994) Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 17:95-134
18. Löscher W, Hönack D, Nolting B, Fassbender CP (1991) Trans-2-envalproate: re-evaluation of its anticonvulsant efficacy in standardized seizure models in mice, rats and dogs. Epilepsy Res 9:195-210
19. Mengel H (1994) Tiagabine. Epilepsia 35 [suppl 5]:S81-S84
20. Nikel B, Shandra AA, Godlevsky LS, Mazarati AM, Kupferberg HJ, Szelenyi I (1993a) Anticonvulsant activity of D-20443 (abstract). Naunyn Schmiedebergs Arch Pharmacol 347[Suppl]:R142
21. Nikel B, Shandra AA, Godlevsky LS, Mazarati AM, Kupferberg HJ, Szelenyi I (1993b) Anticonvulsant effects of it new drug D-20443 (abstract). Epilepsia [Suppl] 34:S95
22. Perreault P, Avoli M (1991) Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices. J Neurophysiol 65:771-785
23. Rogawski MA, Porter RJ (1990) Antiepileptic drugs: pharmacological mechanism and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42:223-286
24. Rostock A, Tober C, Rundfeldt C, Bartsch R, Engel J, Polymeropoulos EE, Kutscher B, Löscher W, Hönack D, White HS, Wolf HH (1996) D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res 23:211-223
25. + channels in neuronal cells. Eur J Pharmacol 336:243-249
26. Rundfeldt C, Rohlfs A, Netzer R (1995a) Multiple actions of the new anticonvulsant D-23129 on voltage-gated inwards currents and GABA-induced currents in cultured neuronal cells (abstract). Naunyn Schmiedeberg's Arch Pharmacol [Suppl] 351:R160
27. Rundfeldt C, Tober C, Ganguly A, Wolf HH, White HS (1995b) Potassium channel opening properties of D-23129 an anticonvulsant with potent effects in rodents models for generalised and focal seizures (abstract). Soc Neurosci Abstr 21:203
28. Rundfeldt C, Armand V, Heinemann U (1997). The anticonvulsant D-23129 (retigabine) is effective in a hippocampal slice model of drug resistant epilepsy (abstract). Soc Neurosci Abstr 840:2162
29. Rutecki PA, Lebeda FJ, Johnston D (1987) 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. J Neurophysiol 57:1911-1924
30. Schafer EW, Brunton RB, Cunningham DJ (1973) A summary of the acute toxicity of 4-aminopyridine to birds and mammals. Toxicol Appl Pharmacol 26:532-538
31. Spencer DD, Spencer SS (1994) Hippocampal resections and the use of human tissue in defining temporal lobe epilepsy syndromes. Hippocampus 4:243-249
32. Spycker DA, Lynch C, Shabanowitz J, Sinn JA (1980) Poisoning with 4-aminopyridine: report of three cases. Clin Toxicol 16:487-497
33. + current in hippocampal neurones. Nature 336:379-381
34. Swanson TH (1995) The pathophysiology of human mesial temporal lobe epilepsy. J Clin Neurophysiol 12:2-22
35. Thesleff S (1980) Aminopyridines and synaptic transmission. Neuroscience 5:1413-1419
36. Tober C, Rundfeldt C, Rostock A, Bartsch R (1994a) The phenyl carbamic acid ester D-23129 is highly effective in epilepsy models for generalised and focal seizures at nontoxic doses (abstract). Soc Neurosci Abstr 20:1641
37. Tober C, Rostock A, Bartsch R (1994b) The phenylcarbamic acid ester D-23129 is highly effective against amygdala-kindled seizures in rats (abstract). Eur J Pharmacol [Suppl] 7:212
38. Tober C, Rostock A, Rundfeldt C, Bartsch R (1996) D-23129: a potent anliconvulsant in the amygdala kindling model of complex partial seizures. Eur J Pharmacol 303:163-169
39. Voskuyl RA, Albus H (1985) Spontaneous epileptiform discharges in hippocampal slices induced by 4-aminopyridine. Brain Res 342:54-66
40. Walther H, Lambert JDC, Jones RSG, Heinemann U, Hamon B (1986) Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium medium. Neurosci Lett 69:156-161
41. Yamaguchi S, Rogawski MA (1992) Effects of anticonvulsant drugs on of 4-aminopyridine-induced seizures in mice. Epilepsy Res 11:9-16
42. Yonekawa WD, Kapetanovic IM, Kupferberg HJ (1995a) The effects of D-23129 (ADD 230001) and standard anticonvulsant on the paired-pulse paradigm in rat hippocampus in vitro (abstract). Soc Neurosci Abstr 21:R2117
43. Yonekawa WD, Kapetanovic IM, Kupferberg HJ (1995b) The effects of anticonvulsant agents on 4-aminopyridine-induced epileptiform activity in rat hippocampus in vitro. Epilepsy Res 20:137-150
44. 2+ induced epileptiform activity in rat temporal cortex slices: development of pharmacoresisianl epileptiform activity. Pflügers Arch [Suppl] 418:R10
45. Zhang CL, Dreier JP, Heinemann U (1995) Paroxysmal epileptiform discharges in temporal Lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res 20:105-111